{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:04:45Z","timestamp":1789362285313,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774266"],"award-info":[{"award-number":["81774266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to evaluate the association between pre-radiotherapy cachexia and treatment discontinuation, as well as other treatment-related outcomes, in patients with head and neck squamous cell carcinoma (HNSCC) receiving definitive radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study consecutively enrolled M0 HNSCC patients who received definitive radiotherapy between July 2023 and December 2025. Cachexia was defined using an operational approach based on core diagnostic variables available in the medical records, informed by the Asian Working Group for Cachexia (AWGC) 2023 criteria. The primary outcome was treatment discontinuation. Secondary outcomes included unplanned radiotherapy interruptions, treatment-related adverse events, timing of acute radiation toxicity, timing of acute myelosuppression, nutritional risk during radiotherapy, and blood transfusion requirements. Logistic regression analyses were performed to assess the association between cachexia and treatment discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 137 patients were included, of whom 72 (52.6%) were classified as having cachexia. Treatment discontinuation was significantly higher in the cachexia group compared to the non-cachexia group (25.0% vs. 4.6%; P&amp;lt;0.001), and the incidence of treatment-related adverse events was also higher (97.2% vs. 78.5%; P&amp;lt;0.001). The distribution of first documented acute radiation toxicity across fraction-based categories differed between groups (P\u00a0=\u00a00.037). No significant differences were observed in unplanned interruptions, timing of acute myelosuppression, nutritional risk, or transfusion requirements. In univariable logistic regression, cachexia was significantly associated with treatment discontinuation (OR\u00a0=\u00a06.89; 95% CI 1.92\u201324.67; P\u00a0=\u00a00.003). After adjustment for age, Eastern Cooperative Oncology Group (ECOG) performance status, and concurrent chemotherapy, cachexia remained significantly associated with treatment discontinuation (OR\u00a0=\u00a06.05; 95% CI, 1.63\u201322.49; P\u00a0=\u00a00.007). Sensitivity analysis using Firth\u2019s penalized logistic regression yielded consistent results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In M0 HNSCC patients receiving definitive radiotherapy, pre-radiotherapy cachexia is significantly associated with treatment discontinuation and is accompanied by a higher incidence of treatment-related adverse events. Assessment of cachexia prior to radiotherapy may provide clinically relevant information on treatment tolerance and help identify patients at high risk of therapy discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1937723","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:35:12Z","timestamp":1789360512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-radiotherapy cachexia is associated with treatment discontinuation in patients with head and neck squamous cell carcinoma receiving definitive radiotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Qianrong","family":"Guo","sequence":"first","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine","place":["Changzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ni","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Li","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[{"name":"Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine","place":["Changzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Changzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine","place":["Changzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianhua","family":"Wu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"Jiangsu Province Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320184","article-title":"Global burden and future trends of head and neck cancer: a deep learning-based analysis (1980-2030)","volume":"20","author":"Hu","year":"2025","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.21733","article-title":"Head and neck cancer: a review","volume":"335","author":"Dunn","year":"2026","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/cancers17050899","article-title":"The emerging role of nanoparticles combined with either radiotherapy or hyperthermia in head and neck cancer: a current review","volume":"17","author":"Vlastou","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2025.4203","article-title":"Treatment interruption and outcomes in head and neck cancer: a secondary analysis of 3 randomized clinical trials","volume":"152","author":"Gharzai","year":"2026","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.12.025","article-title":"Prolongation of definitive head and neck cancer radiotherapy: survival impact and predisposing factors","volume":"156","author":"Xiang","year":"2021","journal-title":"Radiother Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2017.12.209","article-title":"Discontinuation of curative head and neck irradiation: etiologies and outcomes","volume":"100","author":"Lazarev","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0044-1798207","article-title":"Analysis of causes of interruption of radiotherapy treatment in a cancer center","volume":"15","author":"Martiniano","year":"2019","journal-title":"Braz J Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/03008916251367592","article-title":"Predicting severe toxicity after head-and-neck cancer RT: validation of the synergist role of a biological marker and dosimetry","volume":"111","author":"Pereira","year":"2025","journal-title":"Tumori J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34424","article-title":"A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy","volume":"128","author":"Lin","year":"2022","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16386","article-title":"Emotional distress in head-and-neck cancer patients scheduled for chemoradiation or radiotherapy alone","volume":"43","author":"Al-Salool","year":"2023","journal-title":"Anticancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/01455613241228211","article-title":"The trajectory of oral mucositis in head and neck cancer patients undergoing radiotherapy and its influencing factors","volume":"104","author":"Liu","year":"2025","journal-title":"Ear Nose Throat J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.6026\/973206300212104","article-title":"Evaluation of oral mucositis severity and management in head and neck cancer patients undergoing radiotherapy: a prospective study","volume":"21","author":"K","year":"2025","journal-title":"Bioinformation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00066-018-1318-y","article-title":"Factors predicting intolerance to definitive conventional radiotherapy in geriatric patients","volume":"194","author":"Rim","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6549","article-title":"Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors","volume":"12","author":"Murata","year":"2023","journal-title":"Cancer Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-025-02331-7","article-title":"Cancer cachexia: molecular basis and therapeutic advances","volume":"11","author":"Tan","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27288","article-title":"Oropharyngeal dysphagia and cachexia: intertwined in head and neck cancer","volume":"45","author":"Willemsen","year":"2023","journal-title":"Head Neck"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27072","article-title":"Postoperative consequences of cancer cachexia after head and neck free flap reconstruction","volume":"44","author":"Jones","year":"2022","journal-title":"Head Neck-Journal For Sci Specialties Head Neck"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.11.008","article-title":"High prevalence of cachexia in newly diagnosed head and neck cancer patients: an exploratory study","volume":"35","author":"Jager-Wittenaar","year":"2017","journal-title":"Nutrition"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat-muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jjco\/hyy145","article-title":"Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)","volume":"49","author":"Matsuzuka","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S329581","article-title":"Clinical impact of cachexia in head and neck cancer patients who received chemoradiotherapy","volume":"13","author":"Hayashi","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1503294","article-title":"The influence of evidence-based nutritional support plans on the nutritional status and adverse effects of radiotherapy in individuals with nasopharyngeal carcinoma","volume":"12","author":"Fan","year":"2025","journal-title":"Front Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13323","article-title":"Diagnosis and outcomes of cachexia in Asia: working consensus report from the Asian Working Group for Cachexia","volume":"14","author":"Arai","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13703","article-title":"Diagnostic criteria for cancer-associated cachexia: insights from a multicentre cohort study","volume":"16","author":"Huo","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00384-025-04962-2","article-title":"Cancer cachexia onset and survival outcomes in metastatic colorectal cancer","volume":"40","author":"Fujii","year":"2025","journal-title":"Int J Colorectal Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13555","article-title":"AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer","volume":"15","author":"Xie","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21546","article-title":"Changes in nutritional status and dietary intake during and after head and neck cancer treatment","volume":"33","author":"Jager-Wittenaar","year":"2011","journal-title":"Head Neck"},{"key":"B31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00520-023-07952-8","article-title":"Impact of weight loss on treatment interruption and unplanned hospital admission in head and neck cancer patients undergoing curative (chemo)-radiotherapy in Hong Kong","volume":"31","author":"Choi","year":"2023","journal-title":"Support Care Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106978","article-title":"The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: a systematic review and meta-analysis","volume":"157","author":"Schaeffers","year":"2024","journal-title":"Oral Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1669_25","article-title":"Comprehensive analysis of factors affecting toxicities and oncological outcomes in head and neck cancer patients undergoing definitive radiotherapy or chemoradiotherapy","volume":"21","author":"Rahman","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.3390\/cancers14215262","article-title":"Inflammation as a therapeutic target in cancer cachexia","volume":"14","author":"Clamon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2025.100851","article-title":"Head and neck cancer patients present late cancer cachexia two years after curative chemoradiotherapy","volume":"81","author":"das Neves","year":"2025","journal-title":"Clinics (Sao Paulo)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1937723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:35:20Z","timestamp":1789360520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1937723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":35,"alternative-id":["10.3389\/fonc.2026.1937723"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1937723","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1937723"}}